FibroBiologics (FBLG) Prepaid Assets (2022 - 2026)
FibroBiologics (FBLG) posted quarterly Prepaid Assets of $528000.0 for Q2 2026, down 60.39% year-over-year from $1.3 million in Q2 2025, and down 48.24% on a QoQ basis from $1.0 million in Q1 2026.
FibroBiologics (FBLG) Prepaid Assets (2022 - 2026) Analysis & Trends
FibroBiologics has reported Prepaid Assets for 5 years, with the latest figure at $528000.0 in Q2 2026.
- Prepaid Assets for Q2 2026 came in at $528000.0, down 60.39% year-over-year; the trailing twelve-month figure through Jun 2026 was $528000.0 (down 60.39% YoY), and the FY2025 annual result was $1.5 million, up 546.67% from the prior year.
- Prepaid Assets fell to $528000.0 in Q2 2026, from $1.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.5 million in Q4 2025 and troughed at $30000.0 in Q4 2022.
- A 5-year average of $604916.7 and a median of $523000.0 in 2024 frame the typical range for Prepaid Assets.
- The widest annual swing landed in 2025, when Prepaid Assets surged 546.67%; it then sank 60.39% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $30000.0 in 2022, then rose by 20.0% to $36000.0 in 2023, then jumped by 525.0% to $225000.0 in 2024, then surged by 546.67% to $1.5 million in 2025, then plunged by 63.71% to $528000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $528000.0 in Q2 2026, $1.0 million in Q1 2026, and $1.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 528,000.00 |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 373,000.00 |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 642,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 746,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 29,000.00 |